These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21504484)

  • 21. Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data.
    Bassyouni IH; Gheita TA; Talaat RM
    Rheumatology (Oxford); 2011 Nov; 50(11):2108-12. PubMed ID: 21890620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
    J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis.
    Tomčík M; Arima K; Hulejová H; Kuklová M; Filková M; Braun M; Beláček J; Novák M; Bečvář R; Vencovský J; Haluzík M; Gay S; Müller-Ladner U; Distler O; Senolt L
    Cytokine; 2012 May; 58(2):165-8. PubMed ID: 22374311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
    Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
    Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.
    Ostojić P; Damjanov N; Pavlov-Dolijanovic S; Radunović G
    Clin Hemorheol Microcirc; 2004; 31(4):281-5. PubMed ID: 15567898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.
    Wagner A; Köhm M; Nordin A; Svenungsson E; Pfeilschifter JM; Radeke HH
    Scand J Immunol; 2015 Sep; 82(3):269-74. PubMed ID: 26095613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum soluble OX40 in patients with systemic sclerosis.
    Komura K; Yoshizaki A; Kodera M; Iwata Y; Ogawa F; Shimizu K; Wayaku T; Yukami T; Murata M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2359-62. PubMed ID: 18843780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum CCL23 levels are increased in patients with systemic sclerosis.
    Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Asano Y; Kadono T; Sato S
    Arch Dermatol Res; 2011 Jan; 303(1):29-34. PubMed ID: 20824279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
    Sacks DG; Okano Y; Steen VD; Curtiss E; Shapiro LS; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of soluble carbonic anhydrase IX are decreased in patients with diffuse cutaneous systemic sclerosis compared to those with limited cutaneous systemic sclerosis.
    Makino K; Jinnin M; Makino T; Kajihara I; Fukushima S; Inoue Y; Ihn H
    Biosci Trends; 2014 Jun; 8(3):144-8. PubMed ID: 25030848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum leptin, resistin and TNF-α levels in patients with systemic sclerosis: the role of adipokines in scleroderma.
    Pehlivan Y; Onat AM; Ceylan N; Turkbeyler IH; Buyukhatipoglu H; Comez G; Babacan T; Tarakcioglu M
    Int J Rheum Dis; 2012 Aug; 15(4):374-9. PubMed ID: 22898217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hearing loss in diffuse cutaneous systemic scleroderma.
    Monteiro TA; Christmann RB; Bonfá E; Bento RF; Novalo-Goto ES; Vasconcelos LG
    Scand J Rheumatol; 2011 Nov; 40(6):467-71. PubMed ID: 21916804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations.
    Scheja A; Wildt M; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2011 Nov; 40(6):457-61. PubMed ID: 21936615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between adiponectin, leptin, IGF-1 and total lipid peroxides plasma concentrations in patients with systemic sclerosis: possible role in disease development.
    Winsz-Szczotka K; Kuźnik-Trocha K; Komosińska-Vassev K; Kucharz E; Kotulska A; Olczyk K
    Int J Rheum Dis; 2016 Jul; 19(7):706-14. PubMed ID: 24646107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study.
    Almeida I; Oliveira Gomes A; Lima M; Silva I; Vasconcelos C
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):37-42. PubMed ID: 26885625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.